| MWF/FubRkb |
both kidneys wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168 days
| 18 |
|
1.2 |
g |
0.03 |
0.13 |
post excision weight measurement |
|
0.0 |
0 |
|
|
12767 |
309 |
| MWF/FubRkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney mass |
not specified |
168 days
| 18 |
|
5.44 |
g/kg |
0.06 |
0.25 |
post excision weight measurement |
|
0.0 |
0 |
|
|
65366 |
117 |
| MWF/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood urea nitrogen amount |
not specified |
168 days
| 18 |
|
26.22 |
mg/dl |
0.73 |
3.09 |
serum urea analysis |
|
0.0 |
0 |
serum urea analysis |
|
65382 |
117 |
| MWF/FubRkb |
both kidneys wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
kidney mass |
not specified |
126 days
| 8 |
|
1.67 |
g |
0.13 |
0.37 |
post excision weight measurement |
|
0.0 |
0 |
|
|
67595 |
769 |
| MWF/FubRkb |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
kidney glomerulus quantity |
not specified |
126 days
| 8 |
|
19.4 |
null |
1.41 |
4.0 |
ex vivo light microscopy |
|
0.0 |
0 |
|
|
67599 |
769 |
| MWF/FubRkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
kidney mass |
female |
168 days
| 18 |
|
5.78 |
g/kg |
0.01 |
0.06 |
post excision weight measurement |
|
0.0 |
0 |
|
|
68171 |
309 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
30 days
| 5 |
|
0.41 |
g |
0.03 |
0.06 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109695 |
3152 |
| MWF/FubRkb |
systolic blood pressure |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
arterial blood pressure trait |
male |
112 days
| 10 |
|
133.9 |
mmHg |
9.0 |
28.46 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
109410 |
3140 |
| MWF/FubRkb |
heart weight |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
heart mass |
male |
84 days
| 0 |
|
0.69 |
g |
0.03 |
|
post excision weight measurement |
heart |
0.0 |
0 |
|
|
109058 |
3116 |
| MWF/FubRkb |
body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
100 days
| 0 |
|
334.0 |
g |
6.0 |
|
body weighing method |
|
0.0 |
0 |
|
|
108083 |
3115 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
59 days
| 5 |
|
6.8 |
x 10E3 um3 |
0.31 |
0.7 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
glomerular volume per podocyte (CMO:0003748) |
109732 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
female |
30 days
| 5 |
|
80.61 |
g |
3.72 |
8.31 |
body weighing method |
|
0.0 |
0 |
|
|
109704 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
male |
44 days
| 5 |
|
203.06 |
g |
10.29 |
23.0 |
body weighing method |
|
0.0 |
0 |
|
|
109705 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
female |
44 days
| 5 |
|
145.2 |
g |
2.44 |
5.45 |
body weighing method |
|
0.0 |
0 |
|
|
109706 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
31 days
| 5 |
|
254.6 |
null |
13.6 |
30.4 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109721 |
3152 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
31 days
| 5 |
|
3.9 |
x 10E3 um3 |
0.27 |
0.6 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
glomerular volume per podocyte (CMO:0003748) |
109727 |
3152 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
59 days
| 5 |
|
7.4 |
x 10E3 um3 |
0.49 |
1.1 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
glomerular volume per podocyte (CMO:0003748) |
109731 |
3152 |
| MWF/FubRkb |
systolic blood pressure |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
arterial blood pressure trait |
male |
84 days
| 10 |
|
146.0 |
mmHg |
1.0 |
3.16 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
109283 |
3141 |
| MWF/FubRkb |
systolic blood pressure |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
arterial blood pressure trait |
male |
100 days
| 10 |
|
159.0 |
mmHg |
6.0 |
18.97 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
108098 |
3115 |
| MWF/FubRkb |
single kidney wet weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney mass |
female |
168 days
| 10 |
|
1.2 |
g |
0.03 |
0.09 |
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
108926 |
3133 |
| MWF/FubRkb |
single kidney wet weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney mass |
male |
168 days
| 10 |
|
1.99 |
g |
0.08 |
0.25 |
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
108927 |
3133 |
| MWF/FubRkb |
urine total protein excretion rate |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
total urine protein amount |
not specified |
84 days
| 15 |
|
79.1 |
mg/d |
9.5 |
36.79 |
urine total protein analysis |
|
0.0 |
0 |
|
|
109652 |
3149 |
| MWF/FubRkb |
heart left ventricle interstitial fibrotic lesion area to total heart left ventricule area ratio |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
heart left ventricle integrity trait |
not specified |
86 days
| 15 |
|
2.3 |
% |
0.2 |
0.77 |
ex vivo light microscopy with histochemistry and digital image analysis |
heart left ventricle |
0.0 |
0 |
|
|
109669 |
3149 |
| MWF/FubRkb |
heart left ventricle perivascular fibrotic lesion area to total heart left ventricule area ratio |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
heart left ventricle integrity trait |
not specified |
86 days
| 15 |
|
8.8 |
% |
1.2 |
4.65 |
ex vivo light microscopy with histochemistry and digital image analysis |
heart left ventricle |
0.0 |
0 |
|
|
109673 |
3149 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168 days
| 10 |
|
1.86 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
heart left ventricle |
0.0 |
0 |
|
|
108944 |
3133 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
female |
56 days
| 18 |
|
5.2 |
mg/d |
0.9 |
3.82 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
108969 |
3133 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84 days
| 0 |
|
279.3 |
g |
5.5 |
|
body weighing method |
|
0.0 |
0 |
|
|
109039 |
3116 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
body mass |
female |
168 days
| 18 |
|
207.2 |
g |
1.2 |
5.09 |
body weighing method |
|
0.0 |
0 |
|
|
12760 |
309 |
| MWF/FubRkb |
heart wet weight |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168 days
| 18 |
|
0.62 |
g |
0.01 |
0.04 |
post excision weight measurement |
|
0.0 |
0 |
|
|
12768 |
309 |
| MWF/FubRkb |
systolic blood pressure |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
arterial blood pressure trait |
female |
168 days
| 18 |
|
138.5 |
mmHg |
1.2 |
5.09 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
68174 |
309 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
blood creatinine amount |
not specified |
0 days
| 8 |
|
0.49 |
mg/dl |
0.0 |
0.01 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
67605 |
769 |
| MWF/FubRkb |
number of glomeruli per kidney |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-6 days
| 11 |
|
38.0 |
null |
1.81 |
6.0 |
immunofluorescence confocal microscopy |
|
0.0 |
0 |
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
|
109513 |
3145 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
heart mass |
female |
168 days
| 18 |
|
2.98 |
g/kg |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
0 |
|
|
12769 |
309 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
body mass |
not specified |
168 days
| 18 |
|
363.9 |
g |
11.3 |
47.94 |
body weighing method |
|
0.0 |
0 |
|
|
65360 |
117 |
| MWF/FubRkb |
serum triglyceride level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood triglyceride amount |
not specified |
168 days
| 18 |
|
95.58 |
mg/dl |
11.5 |
48.81 |
serum triglyceride analysis |
|
0.0 |
0 |
serum triglyceride analysis |
|
65386 |
117 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
224 days
| 10 |
|
354.6 |
mg/d |
112.9 |
357.02 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
65419 |
117 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
224 days
| 0 |
|
18.6 |
mg/d |
3.0 |
|
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
68186 |
309 |
| MWF/FubRkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84 days
| 10 |
|
148.4 |
% |
16.0 |
50.6 |
wire myography |
|
0.0 |
0 |
|
norepinephrine-induced blood vessel contractile force expressed as percent of force at baseline (CMO:0003676) |
109379 |
3141 |
| MWF/FubRkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasoconstriction trait |
male |
84 days
| 10 |
|
8.3 |
null |
0.2 |
0.63 |
wire myography |
|
0.0 |
0 |
|
logarithm of the concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value (CMO:0003677) |
109384 |
3141 |
| MWF/FubRkb |
body weight |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
body mass |
male |
112 days
| 10 |
|
362.8 |
g |
12.8 |
40.48 |
body weighing method |
|
0.0 |
0 |
|
|
109389 |
3140 |
| MWF/FubRkb |
pulse wave velocity |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
arterial blood pressure trait |
male |
112 days
| 10 |
|
5.6 |
/ms |
0.5 |
1.58 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
109417 |
3140 |
| MWF/FubRkb |
mesenteric artery adventitial thickness |
vehicle control condition |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114 days
| 10 |
|
8.6 |
um |
0.7 |
2.21 |
confocal microscopy |
|
0.0 |
0 |
|
|
109425 |
3140 |
| MWF/FubRkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
|
77.8 |
% |
10.2 |
32.26 |
wire myography |
|
0.0 |
0 |
|
|
109441 |
3140 |
| MWF/FubRkb |
body length, crown to rump |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body length |
not specified |
-6 days
| 11 |
|
13.0 |
mm |
0.3 |
1.0 |
body length measuring method |
|
0.0 |
0 |
|
body length, crown to rump (CMO:0003847) |
109509 |
3145 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84 days
| 0 |
|
5.96 |
mg/g |
0.18 |
|
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
109051 |
3116 |
| MWF/FubRkb |
heart weight to body weight ratio |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
heart mass |
male |
84 days
| 0 |
|
2.55 |
g/kg |
0.08 |
|
post excision weight measurement |
heart |
0.0 |
0 |
|
|
109064 |
3116 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
urine albumin amount |
not specified |
100 days
| 0 |
|
58.1 |
mg/d |
5.8 |
|
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
108108 |
3115 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
kidney mass |
male |
84 days
| 10 |
|
5.25 |
mg/g |
0.1 |
0.32 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109277 |
3141 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
30 days
| 5 |
|
4.9 |
mg/g |
0.13 |
0.3 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109709 |
3152 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
58 days
| 5 |
|
4.4 |
mg/g |
0.13 |
0.3 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109713 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
45 days
| 5 |
|
285.9 |
null |
11.99 |
26.8 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109724 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
168 days
| 10 |
|
108.7 |
mg/d |
12.3 |
38.9 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
108124 |
3116 |
| MWF/FubRkb |
kidney glomerular density |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
kidney glomerulus quantity |
not specified |
84 days
| 8 |
|
7.3 |
/mm3 |
1.6 |
4.53 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109643 |
3149 |
| MWF/FubRkb |
urine albumin excretion rate |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 ml/kg/d) (between 28 and 4 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
46.6 |
mg/d |
7.7 |
29.82 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109663 |
3149 |
| MWF/FubRkb |
heart left ventricle perivascular fibrotic lesion area to total heart left ventricule area ratio |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
heart left ventricle integrity trait |
not specified |
86 days
| 15 |
|
4.5 |
% |
0.3 |
1.16 |
ex vivo light microscopy with histochemistry and digital image analysis |
heart left ventricle |
0.0 |
0 |
|
|
109671 |
3149 |
| MWF/FubRkb |
kidney interstitial fibrotic lesion area to total kidney area ratio |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
kidney integrity trait |
not specified |
86 days
| 15 |
|
5.4 |
% |
1.1 |
4.26 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109681 |
3149 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
heart left ventricle mass |
male |
100 days
| 10 |
|
1.91 |
mg/g |
0.02 |
0.06 |
post excision weight measurement |
|
0.0 |
0 |
|
|
108100 |
3115 |
| MWF/FubRkb |
urine total protein excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
total urine protein amount |
male |
84 days
| 10 |
|
47.5 |
mg/d |
6.7 |
21.19 |
Bradford protein assay |
|
0.0 |
0 |
|
|
108134 |
3116 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
male |
168 days
| 10 |
|
0.42 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
108950 |
3133 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood creatinine amount |
female |
168 days
| 10 |
|
0.47 |
mg/dl |
0.01 |
0.04 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
108951 |
3133 |
| MWF/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
male |
168 days
| 10 |
|
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
108956 |
3133 |
| MWF/FubRkb |
creatinine clearance |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
glomerular filtration trait |
female |
168 days
| 10 |
|
0.0 |
ml/min |
0.0 |
0.0 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
108957 |
3133 |
| MWF/FubRkb |
kidney weight |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84 days
| 0 |
|
1.67 |
g |
0.02 |
|
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
109046 |
3116 |
| MWF/FubRkb |
creatinine clearance |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
glomerular filtration trait |
not specified |
84 days
| 15 |
|
2.36 |
ml/min |
0.14 |
0.54 |
urine creatinine analysis |
|
0.0 |
0 |
|
|
109646 |
3149 |
| MWF/FubRkb |
both kidneys wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney mass |
not specified |
168 days
| 18 |
|
1.99 |
g |
0.08 |
0.34 |
post excision weight measurement |
|
0.0 |
0 |
|
|
65363 |
117 |
| MWF/FubRkb |
serum total cholesterol level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood cholesterol amount |
not specified |
168 days
| 18 |
|
122.01 |
mg/dl |
6.95 |
29.49 |
serum total cholesterol measurement test |
|
0.0 |
0 |
serum triglyceride analysis |
|
65391 |
117 |
| MWF/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
27000.0 |
null |
3500.0 |
9260.13 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
0 |
|
per kidney |
65397 |
117 |
| MWF/FubRkb |
heart wet weight |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
heart mass |
not specified |
168 days
| 18 |
|
0.84 |
g |
0.02 |
0.08 |
post excision weight measurement |
|
0.0 |
0 |
|
|
65369 |
117 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
blood creatinine amount |
not specified |
168 days
| 18 |
|
0.42 |
mg/dl |
0.01 |
0.05 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
65375 |
117 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
44 days
| 5 |
|
0.72 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109697 |
3152 |
| MWF/FubRkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
vasodilation trait |
male |
84 days
| 10 |
|
58.9 |
% |
3.7 |
11.7 |
wire myography |
|
0.0 |
0 |
|
|
109369 |
3141 |
| MWF/FubRkb |
pulse wave velocity |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
arterial blood pressure trait |
male |
112 days
| 10 |
|
5.6 |
/ms |
0.5 |
1.58 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
109418 |
3140 |
| MWF/FubRkb |
mesenteric artery wall thickness |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114 days
| 10 |
|
37.7 |
um |
1.9 |
6.01 |
confocal microscopy |
|
0.0 |
0 |
|
|
109422 |
3140 |
| MWF/FubRkb |
norepinephrine-induced blood vessel contractile force expressed as percent of force of contraction to KCL |
finerenone (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
|
52.9 |
% |
7.9 |
24.98 |
wire myography |
|
0.0 |
0 |
|
|
109442 |
3140 |
| MWF/FubRkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
|
6.9 |
null |
0.1 |
0.32 |
wire myography |
|
0.0 |
0 |
|
|
109445 |
3140 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
7 days
| 0 |
|
13.4 |
g |
0.2 |
|
body weighing method |
|
0.0 |
0 |
|
|
108079 |
3115 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
heart mass |
male |
84 days
| 0 |
|
2.67 |
g/kg |
0.03 |
|
post excision weight measurement |
heart |
0.0 |
0 |
|
|
109063 |
3116 |
| MWF/FubRkb |
urine albumin excretion rate |
sham surgical control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
urine albumin amount |
male |
84 days
| 10 |
|
22.8 |
mg/d |
2.1 |
6.64 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
108123 |
3116 |
| MWF/FubRkb |
both kidneys wet weight to body weight ratio |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
kidney mass |
male |
100 days
| 10 |
|
6.2 |
g/kg |
0.1 |
0.32 |
post excision weight measurement |
|
0.0 |
0 |
|
|
108102 |
3115 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
male |
30 days
| 5 |
|
98.42 |
g |
0.88 |
1.96 |
body weighing method |
|
0.0 |
0 |
|
|
109703 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
male |
58 days
| 5 |
|
241.28 |
g |
4.47 |
10.0 |
body weighing method |
|
0.0 |
0 |
|
|
109707 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
30 days
| 5 |
|
0.11 |
mg/d |
0.02 |
0.04 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109716 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
44 days
| 5 |
|
11.7 |
mg/d |
4.47 |
10.0 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109718 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
31 days
| 5 |
|
248.1 |
null |
13.73 |
30.7 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109722 |
3152 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
31 days
| 5 |
|
3.5 |
x 10E3 um3 |
0.13 |
0.3 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
glomerular volume per podocyte (CMO:0003748) |
109728 |
3152 |
| MWF/FubRkb |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-2 days
| 0 |
|
2.03 |
g |
0.05 |
|
body weighing method |
|
0.0 |
0 |
|
|
108069 |
3115 |
| MWF/FubRkb |
number of ureteric bud tips per kidney |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
ureteric bud morphology trait |
not specified |
-6 days
| 11 |
|
77.0 |
null |
3.62 |
12.0 |
immunofluorescence confocal microscopy |
|
0.0 |
0 |
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of ureteric bud tips per kidney (CMO:0003848) |
109516 |
3145 |
| MWF/FubRkb |
body weight |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
body mass |
male |
84 days
| 10 |
|
302.6 |
g |
4.3 |
13.6 |
body weighing method |
|
0.0 |
0 |
|
|
109274 |
3141 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
heart mass |
male |
84 days
| 10 |
|
2.56 |
g/kg |
0.08 |
0.25 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109280 |
3141 |
| MWF/FubRkb |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-4 days
| 0 |
|
0.62 |
g |
0.01 |
|
body weighing method |
|
0.0 |
0 |
|
|
108068 |
3115 |
| MWF/FubRkb |
tibia length |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
tibia length |
male |
113 days
| 10 |
|
4.2 |
cm |
1.0 |
3.16 |
post excision length measurement |
|
0.0 |
0 |
|
|
109397 |
3140 |
| MWF/FubRkb |
creatinine clearance |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
glomerular filtration trait |
not specified |
84 days
| 15 |
|
0.57 |
ml/min |
0.07 |
0.27 |
urine creatinine analysis |
|
0.0 |
0 |
|
|
109648 |
3149 |
| MWF/FubRkb |
urine albumin excretion rate |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
124.1 |
mg/d |
10.9 |
42.22 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109661 |
3149 |
| MWF/FubRkb |
heart left ventricle interstitial fibrotic lesion area to total heart left ventricule area ratio |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
heart left ventricle integrity trait |
not specified |
86 days
| 15 |
|
1.6 |
% |
0.2 |
0.77 |
ex vivo light microscopy with histochemistry and digital image analysis |
heart left ventricle |
0.0 |
0 |
|
|
109665 |
3149 |
| MWF/FubRkb |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
7 days
| 15 |
|
11.3 |
/mm3 |
2.6 |
10.07 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
0 |
|
number of glomeruli per volume of kidney (CMO:0003799) |
110787 |
3187 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
urine albumin amount |
male |
56 days
| 18 |
|
18.1 |
mg/d |
2.0 |
8.49 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
108965 |
3133 |
| MWF/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney glomerulus quantity |
male |
28 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
27028.0 |
null |
1322.0 |
3497.68 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
0 |
|
|
108972 |
3133 |
| MWF/FubRkb |
serum creatinine level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood creatinine amount |
female |
168 days
| 18 |
|
0.47 |
mg/dl |
0.0 |
0.02 |
serum creatinine analysis |
|
0.0 |
0 |
|
|
68177 |
309 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168 days
| 0 |
|
24.0 |
mg/d |
5.5 |
|
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
68185 |
309 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
urine albumin amount |
not specified |
56 days
| 18 |
|
18.1 |
mg/d |
2.0 |
8.49 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
65273 |
117 |
| MWF/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
glomerular filtration trait |
not specified |
168 days
| 18 |
|
0.46 |
ml/min/100g |
0.05 |
0.21 |
blood creatinine analysis |
|
0.0 |
0 |
|
|
65379 |
117 |
| MWF/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
blood urea nitrogen amount |
female |
168 days
| 18 |
|
26.11 |
mg/dl |
1.09 |
4.63 |
serum urea nitrogen analysis |
|
0.0 |
0 |
|
|
68180 |
309 |
| MWF/FubRkb |
urine albumin excretion rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine albumin amount |
male |
114 days
| 10 |
|
64.4 |
mg/d |
5.6 |
17.71 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109405 |
3140 |
| MWF/FubRkb |
mesenteric artery wall thickness |
vehicle control condition |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114 days
| 10 |
|
36.3 |
um |
1.1 |
3.48 |
confocal microscopy |
|
0.0 |
0 |
|
|
109421 |
3140 |
| MWF/FubRkb |
mesenteric artery adventitial thickness |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114 days
| 10 |
|
7.9 |
um |
0.5 |
1.58 |
confocal microscopy |
|
0.0 |
0 |
|
|
109426 |
3140 |
| MWF/FubRkb |
mesenteric artery media thickness |
vehicle control condition |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114 days
| 10 |
|
19.6 |
um |
0.7 |
2.21 |
confocal microscopy |
|
0.0 |
0 |
|
|
109429 |
3140 |
| MWF/FubRkb |
mesenteric artery media thickness |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
mesenteric artery morphology trait |
male |
114 days
| 10 |
|
19.3 |
um |
0.9 |
2.85 |
confocal microscopy |
|
0.0 |
0 |
|
|
109430 |
3140 |
| MWF/FubRkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasodilation trait |
male |
114 days
| 10 |
|
82.3 |
% |
3.0 |
9.49 |
wire myography |
mesenteric artery |
0.0 |
0 |
|
|
109433 |
3140 |
| MWF/FubRkb |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasodilation trait |
male |
114 days
| 10 |
|
89.6 |
% |
1.6 |
5.06 |
wire myography |
mesenteric artery |
0.0 |
0 |
|
|
109434 |
3140 |
| MWF/FubRkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6 days
| 11 |
|
0.26 |
g |
0.01 |
0.03 |
body weighing method |
|
0.0 |
0 |
|
|
109501 |
3145 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
30 days
| 5 |
|
0.49 |
g |
0.01 |
0.03 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109694 |
3152 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84 days
| 0 |
|
6.18 |
mg/g |
0.1 |
|
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
109052 |
3116 |
| MWF/FubRkb |
heart weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
heart mass |
male |
84 days
| 0 |
|
0.75 |
g |
0.02 |
|
post excision weight measurement |
heart |
0.0 |
0 |
|
|
109057 |
3116 |
| MWF/FubRkb |
timed urine volume |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
urine output |
not specified |
100 days
| 0 |
|
11.3 |
ml/d |
1.1 |
|
metabolic cage urine volume measurement method |
|
0.0 |
0 |
|
|
108104 |
3115 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
44 days
| 5 |
|
4.7 |
mg/g |
0.09 |
0.2 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109711 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
45 days
| 5 |
|
279.7 |
null |
19.23 |
43.0 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109723 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
59 days
| 5 |
|
241.0 |
null |
11.4 |
25.5 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109725 |
3152 |
| MWF/FubRkb |
fetal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
-6 days
| 0 |
|
0.24 |
g |
0.0 |
|
body weighing method |
|
0.0 |
0 |
|
|
108067 |
3115 |
| MWF/FubRkb |
creatinine clearance |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
glomerular filtration trait |
not specified |
84 days
| 15 |
|
0.92 |
ml/min |
0.05 |
0.19 |
urine creatinine analysis |
|
0.0 |
0 |
|
|
109650 |
3149 |
| MWF/FubRkb |
urine albumin excretion rate |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
urine albumin amount |
not specified |
84 days
| 15 |
|
58.1 |
mg/d |
5.8 |
22.46 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109659 |
3149 |
| MWF/FubRkb |
urine total protein excretion rate |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 126 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
total urine protein amount |
male |
168 days
| 10 |
|
308.5 |
mg/d |
24.7 |
78.11 |
Bradford protein assay |
|
0.0 |
0 |
|
|
108138 |
3116 |
| MWF/FubRkb |
single kidney wet weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney mass |
female |
168 days
| 10 |
|
5.78 |
g/kg |
0.13 |
0.41 |
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
108933 |
3133 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
male |
168 days
| 18 |
|
363.9 |
g |
11.3 |
47.94 |
body weighing method |
|
0.0 |
0 |
|
|
108920 |
3133 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
body mass |
female |
168 days
| 18 |
|
207.2 |
g |
1.2 |
5.09 |
body weighing method |
|
0.0 |
0 |
|
|
108921 |
3133 |
| MWF/FubRkb |
urine total protein excretion rate |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
total urine protein amount |
male |
168 days
| 10 |
|
187.5 |
mg/d |
16.3 |
51.55 |
Bradford protein assay |
|
0.0 |
0 |
|
|
108135 |
3116 |
| MWF/FubRkb |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
-2 days
| 15 |
|
11.9 |
/mm3 |
1.8 |
6.97 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
0 |
|
number of glomeruli per volume of kidney (CMO:0003799) |
110785 |
3187 |
| MWF/FubRkb |
heart left ventricle weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
male |
168 days
| 10 |
|
0.68 |
g |
0.02 |
0.06 |
post excision weight measurement |
heart left ventricle |
0.0 |
0 |
|
|
108938 |
3133 |
| MWF/FubRkb |
heart left ventricle weight |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168 days
| 10 |
|
0.5 |
g |
0.01 |
0.03 |
post excision weight measurement |
heart left ventricle |
0.0 |
0 |
|
|
108939 |
3133 |
| MWF/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood urea nitrogen amount |
male |
168 days
| 10 |
|
26.22 |
mg/dl |
0.73 |
2.3 |
serum urea analysis |
|
0.0 |
0 |
|
|
108962 |
3133 |
| MWF/FubRkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
male |
168 days
| 10 |
|
7.5 |
% |
0.5 |
1.58 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
0 |
|
|
108984 |
3133 |
| MWF/FubRkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
female |
168 days
| 10 |
|
4.9 |
% |
0.3 |
0.95 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
0 |
|
|
108985 |
3133 |
| MWF/FubRkb |
kidney weight |
control condition |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
kidney mass |
male |
84 days
| 0 |
|
1.67 |
g |
0.05 |
|
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
109045 |
3116 |
| MWF/FubRkb |
systolic blood pressure |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
arterial blood pressure trait |
not specified |
173 days
| 18 |
|
145.1 |
mmHg |
1.1 |
4.67 |
tail cuff piezoplethysmography |
|
0.0 |
0 |
12-18 recordings on 3 consecutive days |
|
11690 |
117 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
56 days
| 0 |
|
5.2 |
mg/d |
0.8 |
|
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
69944 |
309 |
| MWF/FubRkb |
body weight |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
body mass |
not specified |
126 days
| 8 |
|
333.1 |
g |
6.93 |
19.6 |
body weighing method |
|
0.0 |
0 |
|
|
67593 |
769 |
| MWF/FubRkb |
both kidneys wet weight to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
kidney mass |
not specified |
126 days
| 8 |
|
5.01 |
g/kg |
0.36 |
1.02 |
post excision weight measurement |
|
0.0 |
0 |
|
|
67597 |
769 |
| MWF/FubRkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
kidney glomerulus quantity |
not specified |
126 days
| 8 |
|
2.9 |
null |
0.57 |
1.6 |
ex vivo light microscopy |
|
0.0 |
0 |
|
|
67601 |
769 |
| MWF/FubRkb |
urine total protein excretion rate |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
total urine protein amount |
not specified |
84 days
| 15 |
|
156.4 |
mg/d |
13.5 |
52.29 |
urine total protein analysis |
|
0.0 |
0 |
|
|
109655 |
3149 |
| MWF/FubRkb |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
kidney glomerulus quantity |
not specified |
-6 days
| 11 |
|
0.5 |
null |
0.01 |
0.03 |
immunofluorescence confocal microscopy |
|
0.0 |
0 |
immunofluorescence confocal microscopy with digital image analysis (MMO:0000751) |
number of glomeruli per kidney to number of ureteric bud tips per kidney ratio (CMO:0003849) |
109519 |
3145 |
| MWF/FubRkb |
heart weight to body weight ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
heart mass |
not specified |
168 days
| 18 |
|
2.3 |
g/kg |
0.04 |
0.17 |
post excision weight measurement |
|
0.0 |
0 |
|
|
65372 |
117 |
| MWF/FubRkb |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168 days
| 18 |
|
16.7 |
null |
1.1 |
4.67 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
0 |
|
per section |
65458 |
117 |
| MWF/FubRkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168 days
| 18 |
|
3.8 |
null |
0.8 |
3.39 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
0 |
|
per section |
65461 |
117 |
| MWF/FubRkb |
plasma glucose level |
control condition |
Schulz A, et al., J Am Soc Nephrol 2002 Nov;13(11):2706-14. |
blood glucose amount |
not specified |
0 days
| 8 |
|
157.32 |
mg/dl |
5.6 |
15.84 |
plasma glucose analysis |
|
0.0 |
0 |
|
|
67603 |
769 |
| MWF/FubRkb |
creatinine clearance to body weight ratio |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
glomerular filtration trait |
female |
168 days
| 18 |
|
0.38 |
ml/min/100g |
0.02 |
0.08 |
blood creatinine analysis |
|
0.0 |
0 |
|
|
68183 |
309 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
male |
168 days
| 0 |
|
162.6 |
mg/d |
15.9 |
|
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
68184 |
309 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Schulz A, et al., Clin Sci (Lond). 2007 Oct 22;. |
urine albumin amount |
female |
168 days
| 0 |
|
24.0 |
mg/d |
|
|
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
69947 |
309 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
1 days
| 0 |
|
6.12 |
g |
0.8 |
|
body weighing method |
|
0.0 |
0 |
|
|
108077 |
3115 |
| MWF/FubRkb |
neonatal body weight |
control condition |
Rothermund L, etal., J Hypertens. 2006 Sep 24(9). |
body mass |
not specified |
12 days
| 0 |
|
21.6 |
g |
0.6 |
|
body weighing method |
|
0.0 |
0 |
|
|
108081 |
3115 |
| MWF/FubRkb |
body weight |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
body mass |
male |
112 days
| 10 |
|
350.3 |
g |
9.0 |
28.46 |
body weighing method |
|
0.0 |
0 |
|
|
109390 |
3140 |
| MWF/FubRkb |
timed urine volume |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
urine output |
male |
114 days
| 10 |
|
10.1 |
ml/d |
0.4 |
1.26 |
metabolic cage urine volume measurement method |
|
0.0 |
0 |
|
|
109401 |
3140 |
| MWF/FubRkb |
systolic blood pressure |
vehicle control condition (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
arterial blood pressure trait |
male |
112 days
| 10 |
|
151.5 |
mmHg |
9.0 |
28.46 |
tail cuff plethysmography |
|
0.0 |
0 |
|
|
109409 |
3140 |
| MWF/FubRkb |
heart rate |
vehicle control condition (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
heart pumping trait |
male |
112 days
| 10 |
|
352.3 |
beats/min |
7.3 |
23.08 |
tail cuff plethysmography |
heart |
0.0 |
0 |
|
|
109413 |
3140 |
| MWF/FubRkb |
heart rate |
finerenone (10 mg/kg/d) (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
heart pumping trait |
male |
112 days
| 10 |
|
353.7 |
beats/min |
6.1 |
19.29 |
tail cuff plethysmography |
heart |
0.0 |
0 |
|
|
109414 |
3140 |
| MWF/FubRkb |
negative logarithm of the molar concentration of norepinephrine at which the force of blood vessel contraction is half the maximum value |
finerenone (for 28 days) |
Gil-Ortega M, etal., Am J Nephrol. 2020 Feb 21:1-10. doi: 10.1159/000506275. |
vasoconstriction trait |
male |
114 days
| 10 |
|
6.7 |
null |
0.1 |
0.32 |
wire myography |
|
0.0 |
0 |
|
|
109446 |
3140 |
| MWF/FubRkb |
fetal body weight |
control condition |
Schulte L, etal., J Hypertens. 2012 Oct;30(10):2031-8. doi: 10.1097/HJH.0b013e328356a60a. |
body mass |
not specified |
-6 days
| 11 |
|
0.26 |
g |
0.01 |
0.03 |
body weighing method |
|
0.0 |
0 |
|
|
109508 |
3145 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
44 days
| 5 |
|
0.96 |
g |
0.06 |
0.14 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109696 |
3152 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
male |
58 days
| 5 |
|
1.06 |
g |
0.04 |
0.08 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109699 |
3152 |
| MWF/FubRkb |
kidney weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
58 days
| 5 |
|
0.73 |
g |
0.03 |
0.07 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109700 |
3152 |
| MWF/FubRkb |
body weight |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
body mass |
female |
58 days
| 5 |
|
164.3 |
g |
5.56 |
12.44 |
body weighing method |
|
0.0 |
0 |
|
|
109708 |
3152 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
30 days
| 5 |
|
5.0 |
mg/g |
0.18 |
0.4 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109710 |
3152 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
44 days
| 5 |
|
5.0 |
mg/g |
0.13 |
0.3 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109712 |
3152 |
| MWF/FubRkb |
kidney wet weight to body weight ratio |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
kidney mass |
female |
58 days
| 5 |
|
4.4 |
mg/g |
0.09 |
0.2 |
post excision weight measurement |
|
0.0 |
0 |
|
|
109714 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
30 days
| 5 |
|
0.14 |
mg/d |
0.05 |
0.11 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109715 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
44 days
| 5 |
|
18.4 |
mg/d |
4.65 |
10.4 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109717 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
male |
58 days
| 5 |
|
20.07 |
mg/d |
3.0 |
6.7 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109719 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
urine albumin amount |
female |
58 days
| 5 |
|
9.5 |
mg/d |
2.95 |
6.6 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109720 |
3152 |
| MWF/FubRkb |
number of podocytes per kidney glomerulus |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
59 days
| 5 |
|
248.3 |
null |
19.63 |
43.9 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109726 |
3152 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
male |
45 days
| 5 |
|
6.7 |
x 10E3 um3 |
0.54 |
1.2 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
glomerular volume per podocyte (CMO:0003748) |
109729 |
3152 |
| MWF/FubRkb |
glomerular volume per podocyte |
control condition |
Ijpelaar DH, etal., Am J Physiol Renal Physiol. 2008 Apr;294(4):F758-67. Epub 2008 Jan 16. |
podocyte morphology trait |
female |
45 days
| 5 |
|
5.9 |
x 10E3 um3 |
0.58 |
1.3 |
ex vivo light microscopy with immunohistochemistry and digital image analysis |
|
0.0 |
0 |
|
glomerular volume per podocyte (CMO:0003748) |
109730 |
3152 |
| MWF/FubRkb |
urine albumin excretion rate |
control condition |
Steireif C, etal., J Hypertens. 2013 Nov;31(11):2203-12; discussion 2212. doi: 10.1097/HJH.0b013e3283642384. |
urine albumin amount |
male |
84 days
| 10 |
|
46.2 |
mg/d |
4.0 |
12.65 |
enzyme linked immunosorbent assay |
|
0.0 |
0 |
|
|
109286 |
3141 |
| MWF/FubRkb |
single kidney wet weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney mass |
male |
168 days
| 10 |
|
5.44 |
g/kg |
0.06 |
0.19 |
post excision weight measurement |
kidney |
0.0 |
0 |
|
|
108932 |
3133 |
| MWF/FubRkb |
urine total protein excretion rate |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
total urine protein amount |
not specified |
84 days
| 15 |
|
60.4 |
mg/d |
10.1 |
39.12 |
urine total protein analysis |
|
0.0 |
0 |
|
|
109657 |
3149 |
| MWF/FubRkb |
heart left ventricle interstitial fibrotic lesion area to total heart left ventricule area ratio |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
heart left ventricle integrity trait |
not specified |
86 days
| 15 |
|
3.3 |
% |
0.44 |
1.7 |
ex vivo light microscopy with histochemistry and digital image analysis |
heart left ventricle |
0.0 |
0 |
|
|
109667 |
3149 |
| MWF/FubRkb |
heart left ventricle perivascular fibrotic lesion area to total heart left ventricule area ratio |
left nephrectomy (for 84 days) then controlled ramipril content drinking water (1 mg/kg/d) (for 28 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
heart left ventricle integrity trait |
not specified |
86 days
| 15 |
|
4.3 |
% |
0.7 |
2.71 |
ex vivo light microscopy with histochemistry and digital image analysis |
heart left ventricle |
0.0 |
0 |
|
|
109675 |
3149 |
| MWF/FubRkb |
kidney interstitial fibrotic lesion area to total kidney area ratio |
sham surgical control condition (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
kidney integrity trait |
not specified |
86 days
| 15 |
|
5.0 |
% |
0.4 |
1.55 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109677 |
3149 |
| MWF/FubRkb |
kidney interstitial fibrotic lesion area to total kidney area ratio |
left nephrectomy (for 84 days) |
Rothermund L, etal., Am J Hypertens. 2011 Apr;24(4):474-81. doi: 10.1038/ajh.2010.206. Epub 2010 Sep 23. |
kidney integrity trait |
not specified |
86 days
| 15 |
|
7.8 |
% |
0.6 |
2.32 |
ex vivo light microscopy with histochemistry and digital image analysis |
|
0.0 |
0 |
|
|
109679 |
3149 |
| MWF/FubRkb |
heart left ventricle weight to body weight ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
heart left ventricle mass |
female |
168 days
| 10 |
|
2.42 |
mg/g |
0.04 |
0.13 |
post excision weight measurement |
heart left ventricle |
0.0 |
0 |
|
|
108945 |
3133 |
| MWF/FubRkb |
serum urea nitrogen level |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
blood urea nitrogen amount |
female |
168 days
| 10 |
|
26.11 |
mg/dl |
1.09 |
3.45 |
serum urea analysis |
|
0.0 |
0 |
|
|
108963 |
3133 |
| MWF/FubRkb |
body weight |
controlled NG-nitroarginine methyl ester content drinking water (5 mg/kg/d) (for 42 days) |
Schulz A, etal., Physiol Genomics. 2010 Jun. |
body mass |
male |
84 days
| 0 |
|
270.7 |
g |
4.9 |
|
body weighing method |
|
0.0 |
0 |
|
|
109040 |
3116 |
